TEDCO Closes Out 2022 with Over $1M Investments in Five Maryland Medtech Companies

Published on :

As Maryland continues to blossom as a medtech powerhouse, TEDCO has played an instrumental role in providing capital, resources and mentorship. This was especially true in q4 2022, where TEDCO invested over $1 million combined into LASARRUS, Linshom Medical, NanoBioFAB, CoolTech and Mi-Helper.

TEDCO Invests in SeeTrue Technology

Published on :

TEDCO, Maryland’s economic engine for technology companies, announced today its Builder Fund invested $100,000 in SeeTrue Technology, LLC, a woman-led company seeking to revolutionize the biomedical industry with its micro-injection technology. 

Hood College Receives $2.3M from Hodson Trust in Annual Gift – Hood College News

Published on :

Hood College is proud to announce that The Hodson Trust has gifted $2.3M to the College for use in the Hodson Science and Technology Center expansion project.
This project includes a 32,000-gross-square-foot addition, which includes a new Biomedical Research and Training Center to accommodate growth in STEM programs. The Hodson Science and Technology Center was originally constructed in 1957, with additional renovation projects completed in 2000 and 2014.

TEDCO’s Venture Funds Invests Nearly $1M in Warrior Centric Health

TEDCO logo over a backdrop of the Maryland flag
Published on :

TEDCO, Maryland’s economic engine for technology companies, is pleased to announce its Venture Funds invested nearly $1M in Warrior Centric Health (WCH), an organization that enables healthcare facilities and providers to deliver optimal care to 75 million veterans, active service members, and their families. TEDCO’s evergreen Venture Funds are dedicated to funding and growing the next generation of early-stage businesses in Maryland.

Peroxitech Announces Closing of $25M Series A Financing to Develop Novel Treatment for Acute Lung Injury

Published on :

Peroxitech Inc., an emerging biopharmaceutical company developing a novel peptide for treating acute lung injury (ALI), announced the successful completion of a Series A financing round of $25 million led by the Perceptive Xontogeny Venture Fund (“PXV Fund”). The company will use the proceeds to build upon the preclinical work conducted through collaborative partnership and seed investment with the Xontogeny development team to advance the lead candidate, PIP-2, through IND-enabling studies and into clinical development.

iECURE Snags $65 Million to Support Knock-In Gene Editing Asset for OTC Deficiency

Published on :

Philadelphia-based iECURE, which is collaborating with Jim Wilson’s Gene Therapy Program (GTP) at University of Pennsylvania, secured $65 million in Series A-1 financing to support its knock-in gene editing therapeutics for liver disorders. Combined with $50 million raised in a previous Series A round, iECURE is well-financed to take its lead asset, GTP-506 into the clinic.

TEDCO’s Pre-Seed Builder Fund Invests in NanoBioFAB

Published on :

TEDCO, Maryland’s economic engine for technology companies, announced today its Builder Fund invested in NanoBioFAB, a Frederick, Md.  technology start-up. TEDCO’s Builder Fund invests in and provides executive support to Maryland-based technology companies run by entrepreneurs who demonstrate economic disadvantage.